How is amniotic fluid embolism recognized and managed in a pregnant or postpartum woman?

Amniotic Fluid Embolism: Recognition and Management

Clinical Recognition

Amniotic fluid embolism (AFE) should be immediately suspected in any laboring or recently delivered woman who experiences sudden cardiorespiratory collapse, particularly when followed by coagulopathy. 1 The diagnosis is entirely clinical—no laboratory test can confirm or refute it. 1

Classic Presentation Triad

• Sudden hypoxia with acute respiratory failure 1
• Hypotension with cardiovascular collapse or cardiac arrest 1
• Coagulopathy (disseminated intravascular coagulation), which may appear immediately or develop in later phases 1

Timing and Context

• 70% occur during labor, 11% after vaginal delivery, and 19% during cesarean delivery 1
• Onset is typically during labor or within 30 minutes after placental delivery 2
• May also present with seizures or severe respiratory difficulty 1

Critical Differential Diagnoses

Consider and exclude: 1, 2

• Pulmonary embolism
• Myocardial infarction (check cardiac troponins and 12-lead ECG in patients with risk factors: advanced maternal age, diabetes, chronic hypertension, smoking, obesity) 1
• Air embolism
• Anesthetic complications or high spinal block
• Anaphylaxis
• Eclampsia
• Sepsis

Important caveat: Do not diagnose AFE based solely on hemorrhage from persistent uterine atony with secondary coagulopathy—this is a common diagnostic error. 1

Immediate Management Algorithm

1. Cardiopulmonary Resuscitation (If Cardiac Arrest)

Initiate immediate high-quality CPR using standard BLS/ACLS protocols. 1

• Manual uterine displacement or lateral tilt to relieve aortocaval compression 2
• Use backboard for effective compressions 2
• If no pulse at 4 minutes, immediately begin perimortem cesarean delivery (resuscitative hysterotomy) for fetuses ≥23 weeks gestation 1, 2
• Consider moving to operating room only if achievable within 2 minutes or less 2

2. Multidisciplinary Team Activation

Immediately assemble a team including anesthesia, respiratory therapy, critical care, and maternal-fetal medicine. 1 Designate a timekeeper to call out times at 1-minute intervals. 2

3. Respiratory Support

Provide adequate oxygenation and ventilation immediately. 1

• Intubation and mechanical ventilation are typically required 3
• Perform transthoracic or transesophageal echocardiography as soon as possible to identify right ventricular failure, which is common in AFE 3

4. Hemodynamic Management

Use vasopressors and inotropic agents based on hemodynamic status; avoid excessive fluid administration. 1

• If right ventricular failure is identified on echocardiography: 3
  • Initiate inotropic agents to improve right ventricular performance
  • Use pulmonary vasodilators
  • Prefer vasopressors over fluid infusion in severe right ventricular compromise
• Excessive fluid can worsen right ventricular function and pulmonary edema 1

5. Coagulopathy Management

Assess clotting status early and manage clinical bleeding aggressively with massive transfusion protocols. 1

Hemostatic Resuscitation Protocol:

• Do not delay blood product administration while awaiting laboratory results in massive hemorrhage 1
• Administer packed red blood cells, fresh-frozen plasma, and platelets at a 1:1:1 ratio 1, 3
• Add cryoprecipitate as needed to maintain fibrinogen >150-200 mg/dL 3
• Target platelet count >50,000/mm³ 1
• Maintain near-normal aPTT and INR 1

Antifibrinolytic Therapy:

• Hyperfibrinolysis is common in AFE-related coagulopathy 1
• When available, use bedside thromboelastography to identify patients who may benefit from antifibrinolytics 1
• Consider tranexamic acid or epsilon aminocaproic acid if hyperfibrinolysis is identified 1

Recombinant Factor VIIa:

• Use only as last resort when hemorrhage cannot be stopped with massive transfusion and surgical interventions 1
• Risk: May cause excessive diffuse thrombosis and multiorgan failure in AFE patients with elevated tissue factor 1

6. Management of Uterine Atony

Uterine atony is common with AFE and requires aggressive management. 1, 2

Stepwise Approach:

• Medical management: Oxytocin prophylaxis plus additional uterotonics (ergot derivatives, prostaglandins) as indicated 1, 2
• Uterine tamponade: Packing or intrauterine balloons for refractory cases 1
• Surgical interventions: Bilateral uterine artery ligation, B-Lynch stitch, or hysterectomy for extreme cases 1
• For vaginal deliveries: Thoroughly inspect cervix and vagina to rule out lacerations contributing to bleeding in the setting of DIC 1
• For cesarean deliveries with diffuse bleeding not amenable to surgical control: Consider pelvic packing and ICU transfer with delayed closure 1

7. Advanced Therapies for Refractory Cases

Consider venoarterial extracorporeal membrane oxygenation (VA-ECMO) for prolonged CPR or severe ventricular dysfunction refractory to medical management. 3, 4

Key Clinical Pitfalls

• Do not wait for laboratory confirmation—AFE is a clinical diagnosis of exclusion 1
• Do not over-resuscitate with fluids in the setting of right ventricular failure 1, 3
• Do not diagnose AFE based solely on atonic bleeding—this misses the cardiorespiratory collapse component 1
• Do not delay perimortem cesarean delivery—begin at 4 minutes of pulselessness 1, 2
• Do not use recombinant factor VIIa early—reserve for last-resort situations 1

Prognosis

AFE carries a case fatality rate exceeding 50% in classic cases with cardiovascular collapse and coagulopathy. 2 Even with optimal management, significant maternal and perinatal morbidity and mortality occur. 1 Survivors may experience long-term neurological deficits and cardiac complications. 4